These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 20697002)

  • 21. Captopril and vascular endothelial growth factor in a mouse model of retinopathy.
    Higgins RD; Yan Y; Geng Y; Sharma J; Barr SM
    Curr Eye Res; 2003 Aug; 27(2):123-9. PubMed ID: 14632165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity.
    Saito Y; Geisen P; Uppal A; Hartnett ME
    Mol Vis; 2007 Jun; 13():840-53. PubMed ID: 17615545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rofecoxib inhibits retinal neovascularization via down regulation of cyclooxygenase-2 and vascular endothelial growth factor expression.
    Liu NN; Sun YZ; Zhao N; Chen L
    Clin Exp Ophthalmol; 2015 Jul; 43(5):458-65. PubMed ID: 25472856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy.
    Simmons AB; Bretz CA; Wang H; Kunz E; Hajj K; Kennedy C; Yang Z; Suwanmanee T; Kafri T; Hartnett ME
    Angiogenesis; 2018 Nov; 21(4):751-764. PubMed ID: 29730824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model.
    Zhang W; Yokota H; Xu Z; Narayanan SP; Yancey L; Yoshida A; Marcus DM; Caldwell RW; Caldwell RB; Brooks SE
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6384-95. PubMed ID: 21705685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity.
    Wang H; Yang Z; Jiang Y; Hartnett ME
    Mol Vis; 2014; 20():231-41. PubMed ID: 24623966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of mRNA of vascular endothelial growth factor in a rat model of hyperoxia-induced retinopathy].
    Zhang ZH; Jiang L; Qiao LX
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):371-4. PubMed ID: 17706045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model.
    Byfield G; Budd S; Hartnett ME
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3360-5. PubMed ID: 19264880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease.
    Hartnett ME; Martiniuk D; Byfield G; Geisen P; Zeng G; Bautch VL
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3107-14. PubMed ID: 18378573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-126 inhibits pathological retinal neovascularization via suppressing vascular endothelial growth factor expression in a rat model of retinopathy of prematurity.
    Fan YY; Liu CH; Wu AL; Chen HC; Hsueh YJ; Chen KJ; Lai CC; Huang CY; Wu WC
    Eur J Pharmacol; 2021 Jun; 900():174035. PubMed ID: 33727052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy.
    Chen J; Joyal JS; Hatton CJ; Juan AM; Pei DT; Hurst CG; Xu D; Stahl A; Hellstrom A; Smith LE
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2968-77. PubMed ID: 22491401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat.
    Dorey CK; Aouididi S; Reynaud X; Dvorak HF; Brown LF
    Arch Ophthalmol; 1996 Oct; 114(10):1210-7. PubMed ID: 8859080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity.
    McCloskey M; Wang H; Jiang Y; Smith GW; Strange J; Hartnett ME
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2020-6. PubMed ID: 23449716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of somatostatin analogues on retinal angiogenesis in a mouse model of oxygen-induced retinopathy: involvement of the somatostatin receptor subtype 2.
    Dal Monte M; Ristori C; Cammalleri M; Bagnoli P
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3596-606. PubMed ID: 19324858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
    Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal Delivery of VEGF-A
    Mezu-Ndubuisi OJ; Wang Y; Schoephoerster J; Falero-Perez J; Zaitoun IS; Sheibani N; Gong S
    Curr Eye Res; 2019 Mar; 44(3):275-286. PubMed ID: 30383455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of vascular endothelial growth factor-induced retinal neovascularization by retinoic acid in experimental retinopathy of prematurity.
    Ozkan H; Duman N; Kumral A; Kasap B; Ozer EA; Lebe B; Yaman A; Berk T; Yilmaz O; Ozer E
    Physiol Res; 2006; 55(3):267-275. PubMed ID: 16083310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of strain-dependent differential gene expression in oxygen-induced retinopathy in the rat.
    van Wijngaarden P; Brereton HM; Gibbins IL; Coster DJ; Williams KA
    Exp Eye Res; 2007 Oct; 85(4):508-17. PubMed ID: 17692314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA-Seq Provides Insights into VEGF-Induced Signaling in Human Retinal Microvascular Endothelial Cells: Implications in Retinopathy of Prematurity.
    Ramshekar A; Bretz CA; Hartnett ME
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy.
    Wilkinson-Berka JL; Babic S; De Gooyer T; Stitt AW; Jaworski K; Ong LG; Kelly DJ; Gilbert RE
    Am J Pathol; 2004 Apr; 164(4):1263-73. PubMed ID: 15039215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.